Infectious Diseases
Should Not Kill Anyone

Universal Infectious Diseases Test (UID)

A Revolutionary Technology to Aid the Clinician

Sepsis And Its Global Impact

Sepsis is the body's extreme response to an infection and is potentially life-threatening. This occurs when a pre-existing infection
triggers a chain reaction throughout your body, often leading to shock, disability, multi organ failure, or even death.

SEPSIS IS A LEADING CAUSE OF DEATH

Source: WHO 2020 DATA
  • Sepsis 11Mn
  • TB 1.5Mn
  • Cancer 10Mn
  • Stroke 6Mn

>2 BILLION PEOPLE WITH THE FOLLOWING PRE-EXISTING
CONDITIONS ARE AT A HIGHER RISK OF SEPSIS

18.5
million
CANCER PATIENTS
422
million
DIABETES PATIENTS
>1.5
billion
HYPERTENSION PATIENTS
140
million
IMMUNE COMPROMISED PATIENTS

The Universal Infectious Diseases Test

UID Test is an NGS based culture-free test to identify causative pathogen in a quick turn around time

1200+ PATHOGENS

1200+ PATHOGENS

Comprehensive single screening test covering bacteria and fungi

ARG PROFILING

ARG PROFILING

Identifies drug resistance based on Antibiotic Resistance Gene (ARG) profile

RESULT REPORTED IN < 12 HOURS

RESULT REPORTED IN < 12 HOURS

Hands on time < 4 hours

The Current System Needs An Upgrade To Save Lives

Tests for
ID
Turn
Around Time
Pathogen
Coverage
Antibiotic
Coverage
Additional
Information
UID Test
12 hours
>1200 pathogens
ARGs
Species and Genus identification
Culture Test
2-10 Days
Culturable bacteria and fungi
Selected Panel
Molecular Test
12-24 Hours
Up to 43 pathogens
1-5 Antibiotics
Upgradation of technology on existing set up is not possible or is very difficult

Our Partners

100+

CITIES

100+

HOSPITALS

500+

DOCTORS

In the news

COVID-19 led to a spike in Tuberculosis cases in India: Experts

24 April 2022 | The Times of India

COVID-19 led to a spike in Tuberculosis cases in India: Experts

Read more

Early Detection and Accurate Diagnosis crucial to make India TB Free by 2025 - HaystackAnalytics Insights

24 March 2022 | Medgate today Magazine

Early Detection and Accurate Diagnosis crucial to make India TB Free by 2025 - HaystackAnalytics Insights

Read more

HaystackAnalytics develops first Universal Infectious Disease (ID) genomic test

7 February 2022 | The Economic Times

HaystackAnalytics develops first Universal Infectious Disease (ID) genomic test

Read more

Public Health: Tech a formidable ally against TB

22 January 2022 | Financial Express

Public Health: Tech a formidable ally against TB

Read more

Awards & Recognition